Nanobiotix S.A. - Sponsored ADR (NBTX) vs Zenas BioPharma, Inc. (ZBIO)

Nanobiotix S.A. - Sponsored ADR and Zenas BioPharma, Inc. are both Biotechnology companies. Nanobiotix S.A. - Sponsored ADR and Zenas BioPharma, Inc. are of similar size ($1.8B and $1.7B). Across the 8 metrics below, Nanobiotix S.A. - Sponsored ADR leads on 6 and Zenas BioPharma, Inc. on 2.

Valuation

Metric NBTX ZBIO Biotechnology median
P/E n/m n/m 7.88
P/S 6,653.21 n/m 11.47
P/B n/m 6.95 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 6,561.31 n/m 10.73
Earnings yield (9.97%) (33.02%) (28.84%)
Free cash flow yield (12.57%) (13.15%) (23.03%)

Profitability

Metric NBTX ZBIO Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (199.04%) (57.72%)
Return on assets 0.00% (97.39%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NBTX ZBIO Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 63.46% 29.04% —
Revenue growth, 5-year CAGR 66.64% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NBTX ZBIO Biotechnology median
Debt to equity 0.00 1.57 0.00
Current ratio 1.09 9.93 4.73
Net debt to EBITDA 5.66 0.69 0.96

Dividend

Metric NBTX ZBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric NBTX ZBIO Biotechnology median
Market cap 1.69b 1.79b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack